Extracellular Vesicles: Biomarkers and Regulators of Vascular Function During Extracorporeal Circulation

Overview

Journal Oncotarget

Specialty Oncology

Date 2019 Jan 17

PMID 30647856

Citations 7

Authors

Mark J McVey

Wolfgang M Kuebler

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs) are generated at increased rates from parenchymal and circulating blood cells during exposure of the circulation to abnormal flow conditions and foreign materials associated with extracorporeal circuits (ExCors). This review describes types of EVs produced in different ExCors and extracorporeal life support (ECLS) systems including cardiopulmonary bypass circuits, extracorporeal membrane oxygenation (ECMO), extracorporeal carbon dioxide removal (ECCOR), apheresis, dialysis and ventricular assist devices. Roles of EVs not only as biomarkers of adverse events during ExCor/ECLS use, but also as mediators of vascular dysfunction are explored. Manipulation of the number or subtypes of circulating EVs may prove a means of improving vascular function for individuals requiring ExCor/ECLS support. Strategies for therapeutic manipulation of EVs during ExCor/ECLS use are discussed such as accelerating their clearance, preventing their genesis or pharmacologic options to reduce or select which and how many EVs circulate. Strategies to reduce or select for specific types of EVs may prove beneficial in preventing or treating other EV-related diseases such as cancer.

Citing Articles

Extracellular vesicles and preterm infant diseases.

Chen W, Kongsomros S, Thorman A, Esfandiari L, Morrow A, Chutipongtanate S Front Pediatr. 2025; 13:1550115.

PMID: 40034714 PMC: 11873092. DOI: 10.3389/fped.2025.1550115.

Plasma leukocyte-derived extracellular vesicles are related to target vessel revascularization in off-pump coronary artery bypass grafting.

Urbanowicz T, Gasecka A, Olasinska-Wisniewska A, Michalak M, Rodzki M, Blazejowska E Postepy Kardiol Interwencyjnej. 2025; 20(4):433-442.

PMID: 39897018 PMC: 11783267. DOI: 10.5114/aic.2024.145576.

Extracellular vesicles as markers and mediators of pregnancy complications: gestational diabetes, pre-eclampsia, preterm birth and fetal growth restriction.

Farrelly R, Kennedy M, Spencer R, Forbes K J Physiol. 2023; 601(22):4973-4988.

PMID: 37070801 PMC: 11497252. DOI: 10.1113/JP282849.

Endogenous and exogenous protection from surgically induced reactive oxygen and nitrogen species.

Mathis B, Kato H, Matsuishi Y, Hiramatsu Y Surg Today. 2022; 54(1):1-13.

PMID: 36348164 DOI: 10.1007/s00595-022-02612-6.

Extracellular Vesicles as an Index for Endothelial Injury and Cardiac Dysfunction in a Rodent Model of GDM.

Kereliuk S, Xiao F, Burger D, Dolinsky V Int J Mol Sci. 2022; 23(9).

PMID: 35563365 PMC: 9101204. DOI: 10.3390/ijms23094970.

References

Wu , Kapadvanjwala , DE , Dewanjee , Novak , Hsu . Reduction of Platelet Thrombi and Emboli by L-Arginine during Cardiopulmonary Bypass in a Pig Model. J Thromb Thrombolysis. 1996; 3(4):343-360. DOI: 10.1007/BF00133078. View

Brown 3rd C, Leverett L, Lewis C, ALFREY Jr C, Hellums J . Morphological, biochemical, and functional changes in human platelets subjected to shear stress. J Lab Clin Med. 1975; 86(3):462-71. View

Nomura S, Tandon N, Nakamura T, Cone J, Fukuhara S, Kambayashi J . High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis. 2001; 158(2):277-87. DOI: 10.1016/s0021-9150(01)00433-6. View

Silber H, Bluemke D, Ouyang P, Du Y, Post W, Lima J . The relationship between vascular wall shear stress and flow-mediated dilation: endothelial function assessed by phase-contrast magnetic resonance angiography. J Am Coll Cardiol. 2001; 38(7):1859-65. DOI: 10.1016/s0735-1097(01)01649-7. View

Piguet P, Vesin C . Modulation of platelet caspases and life-span by anti-platelet antibodies in mice. Eur J Haematol. 2002; 68(5):253-61. DOI: 10.1034/j.1600-0609.2002.01444.x. View

van den Goor J, van den Brink A, Nieuwland R, van Oeveren W, Rutten P, Tepaske R . Generation of platelet-derived microparticles in patients undergoing cardiac surgery is not affected by complement activation. J Thorac Cardiovasc Surg. 2003; 126(4):1101-6. DOI: 10.1016/s0022-5223(03)01031-6. View

Wendler T, Schilling R, Lennertz A, Sodemann K, Kleophas W, Messner H . Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study. J Clin Apher. 2003; 18(4):157-66. DOI: 10.1002/jca.10071. View

Brodsky S, Zhang F, Nasjletti A, Goligorsky M . Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004; 286(5):H1910-5. DOI: 10.1152/ajpheart.01172.2003. View

Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T . Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin Appl Thromb Hemost. 2004; 10(2):133-41. DOI: 10.1177/107602960401000203. View

10.

Kondo N, Wakayama F, Suzuki Y, Fukui K, Takaya S, Fukuda I . The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor. Thromb Res. 2004; 113(5):303-10. DOI: 10.1016/j.thromres.2004.03.017. View

11.

Tramontano A, OLeary J, Black A, Muniyappa R, Cutaia M, El-Sherif N . Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem Biophys Res Commun. 2004; 320(1):34-8. DOI: 10.1016/j.bbrc.2004.05.127. View

12.

Nomura S, Inami N, Kanazawa S, Iwasaka T, Fukuhara S . Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells. 2004; 22(5):696-703. DOI: 10.1634/stemcells.22-5-696. View

13.

Rhodes N, Shortland A, Rattray A, Black R, Williams D . Activation status of platelet aggregates and platelet microparticles shed in sheared whole blood. J Mater Sci Mater Med. 2004; 8(12):747-51. DOI: 10.1023/a:1018556427716. View

14.

Chung A, Wildhirt S, Wang S, Koshal A, Radomski M . Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study. J Thorac Cardiovasc Surg. 2005; 129(4):782-90. DOI: 10.1016/j.jtcvs.2004.06.049. View

15.

Lancaster G, Febbraio M . Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J Biol Chem. 2005; 280(24):23349-55. DOI: 10.1074/jbc.M502017200. View

16.

Cheng C, van Haperen R, de Waard M, van Damme L, Tempel D, Hanemaaijer L . Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood. 2005; 106(12):3691-8. DOI: 10.1182/blood-2005-06-2326. View

17.

Amabile N, Guerin A, Leroyer A, Mallat Z, Nguyen C, Boddaert J . Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005; 16(11):3381-8. DOI: 10.1681/ASN.2005050535. View

18.

Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y . Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006; 4(3):566-73. DOI: 10.1111/j.1538-7836.2005.01780.x. View

19.

Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld J . Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int. 2006; 69(8):1416-23. DOI: 10.1038/sj.ki.5000306. View

20.

Rand M, Wang H, Bang K, Packham M, Freedman J . Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost. 2006; 4(7):1621-3. DOI: 10.1111/j.1538-7836.2006.02011.x. View